Skip to content
Recall Observatory FDA recall evidence

Drug product

Glenmark Ranitidine Tablets USP 150 mg Rx Only 60 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ NDC 68462-248-60

D-0639-2020

December 17, 2019

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 84516
Status
Ongoing
Classification
Class II
Quantity
208,668 bottles
Official record key
drug-enforcement:D-0639-2020

Official wording

Reason: CGMP Deviations: Presence of NDMA impurity detected in product.

Code information: 7701164A 7701471A 7701670B 7701827A 7702242A 7702705A 7702947A 7703408A 7704494A 7704495A 19190289 19190342 19190372 7702737A

Distribution pattern: Natiowide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    NDMA impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations